Cerebral palsy is a prevalent neurodevelopmental disorder that ranging from 1.5 to 2.5/1000 births beginning in the early childhood and continues throughout life. It causing the non-progressive disturbance of motor function that influences posture and movement, motor coordination with secondary complications of contractures and bone deformity. These alternations leading to hindrance in independent performance of daily activities. Cerebral palsy, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients between 5 to 10 years old Diagnosed as hemiplegic cerebral palsy Both genders will include Being able to cooperate and being motivated will include in the study Patients who are able to understand and clearly follow verbal instructions and command that include in training and evaluation. Patients with Gross Motor Function Classification Scale level 1, 2 and 3 will include
Exclusion criteria
Exclusion criteria: Patients with visual impairments and auditory problem Patients with severe spasticity (Modified Ashworth spasticity score of 4) excluded from the study Patients with Psychological illness Participants Suffered from uncontrolled seizures Patients injected with Botulinum toxin injections within past three months were excluded Patients having prior surgery for spasticity within past 3 months were excluded from study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Spasticity and impaired range of motion in the upper extremity. Timepoint: motor function will be measured at start of treatment sessions and after eight weeks after treatment sessions finished. Method of measurement: modified ashworth scale will use.;Motor dysfunction in the upper limb. Timepoint: motor function will be measured at start of treatment sessions and after eight weeks after treatment sessions finished. Method of measurement: ABILHAND - KIDS and PMAL scale will use. | — |
Countries
Pakistan
Contacts
The University of Faisalabad